Chronically Mildly Elevated Hematocrit, Hemoglobin, and RBC Count in a 54-Year-Old Woman
The most important condition to rule out is polycythemia vera (PV), a myeloproliferative neoplasm that requires JAK2 mutation testing as the primary diagnostic step, followed by evaluation for secondary causes of erythrocytosis including chronic hypoxia, sleep apnea, smoking, renal disorders, and less commonly, hereditary hemochromatosis. 1
Primary Diagnostic Consideration: Polycythemia Vera
The WHO diagnostic criteria for PV in women require hemoglobin >16.5 g/dL or hematocrit >48%, or a sustained increase of ≥2 g/dL from baseline 1. However, your patient has only "mildly elevated" values, which creates diagnostic complexity.
Key Diagnostic Steps for PV:
Major Criteria 1:
- Elevated hemoglobin/hematocrit above thresholds OR sustained increase ≥2 g/dL from baseline
- Presence of JAK2V617F or JAK2 exon 12 mutation
- Bone marrow showing trilineage myeloproliferation
- Subnormal serum erythropoietin level
- Endogenous erythroid colony growth
PV diagnosis requires both major criteria plus one minor criterion, OR the first major criterion plus two minor criteria 1.
Critical Pitfall - Masked Polycythemia Vera:
A subset of PV patients present with normal or only mildly elevated hemoglobin/hematocrit due to blood dilution, iron deficiency, or coincidental blood loss 3, 4. Iron deficiency can mask the true elevation in red cell mass 2. In one case series, a 50-year-old woman with elevated hemoglobin had concurrent iron deficiency that obscured the diagnosis 3. Therefore, check iron studies and consider that correction of iron deficiency may unmask higher hemoglobin levels 2.
Secondary Causes of Erythrocytosis
After excluding PV, evaluate for:
Hypoxia-Related Causes:
- Chronic lung disease (COPD, interstitial lung disease)
- Sleep apnea - particularly relevant in middle-aged women
- High altitude residence
- Smoking - increases carboxyhemoglobin
- Cyanotic heart disease (right-to-left shunts)
Renal and Hormonal Causes:
- Renal artery stenosis or other renal disorders causing inappropriate erythropoietin production
- Erythropoietin-secreting tumors (renal cell carcinoma, hepatocellular carcinoma, uterine fibroids, cerebellar hemangioblastoma)
Other Considerations:
- Hereditary hemochromatosis - presents with erythrocytosis and elevated hemoglobin, though typically with normal iron studies in pediatric cases; in adults, check transferrin saturation and ferritin 5
- Relative (apparent) polycythemia - decreased plasma volume without true increase in red cell mass (dehydration, diuretic use, stress erythrocytosis/Gaisböck syndrome)
Recommended Diagnostic Algorithm
Obtain JAK2V617F mutation testing immediately - this is the single most important test 1, 6
Check complete iron panel (serum iron, TIBC, ferritin, transferrin saturation) - iron deficiency may mask PV 2, 3
Measure serum erythropoietin level:
If JAK2 positive: Proceed with bone marrow biopsy to confirm PV diagnosis 1
If JAK2 negative but clinical suspicion remains: Consider JAK2 exon 12 mutation testing and bone marrow biopsy 2
Evaluate for secondary causes:
- Pulse oximetry/arterial blood gas
- Sleep study if symptoms suggest sleep apnea
- Renal ultrasound with Doppler
- Abdominal imaging if erythropoietin elevated (to exclude tumors)
- Smoking history and carboxyhemoglobin level
Important Clinical Context
The 2016 WHO criteria lowered diagnostic thresholds for PV, which increased overlap with normal reference ranges 7. In one study of 248,839 patients with normal CBC results, 6.48% of men and 0.28% of women met the new hemoglobin/hematocrit thresholds 7. This means borderline elevations should only trigger extensive workup when accompanied by other clinical or laboratory features suggestive of myeloproliferative neoplasm 7.
The prognosis of masked PV (normal hemoglobin with JAK2 mutation) appears worse, especially with older age and leukocytosis 4. Any history of unusual site thrombosis (portal vein, splenic vein, hepatic vein) mandates JAK2 testing regardless of hemoglobin level 4.